Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China 2023-04-19 08:12
Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting 2023-04-19 07:00
Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial 2023-04-18 21:00
Biosyngen announces FDA IND approval of its second product for EBV-positive lymphoma 2023-04-18 19:03
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration 2023-04-18 17:16
GC Genome to Present the Brand New Liquid Biopsy Platform for Cancer Detection at AACR Annual Meeting 2023 2023-04-18 13:36
West Korea Announces Ready Pack™ Containment Solution Extension at COPHEX 2023 2023-04-18 10:00
GC Biopharma celebrates 'World Hemophilia Day' 2023-04-18 09:03
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023 2023-04-18 08:00
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023 2023-04-18 08:00
Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease 2023-04-18 08:00
Innovent Announces Updated Data of Phase 1 Clinical Trial for IBI351 (KRAS[G12C] Inhibitor) as Monotherapy for Solid Tumors at the AACR Annual Meeting 2023 2023-04-18 08:00
Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting 2023-04-18 04:15
Promising Efficacy of AT101 CAR-T for Blood Cancer 2023-04-18 02:00
Asieris Releases 2022 Annual Report: Makes Steady Progress in its Clinical Development, Global Expansion to Treat Genitourinary Tumors, and Implementing its Commercialization Strategy to Provide Integrated Diagnosis-to-Treatment Solutions 2023-04-17 18:30
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter 2023-04-17 18:15
Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development 2023-04-17 16:50
Late-Breaking Research - Alphamab Oncology Presents Preclinical Results of KN052 at AACR 2023 2023-04-17 14:01
AffaMed Therapeutics Announces Approval to Initiate a Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery 2023-04-17 09:00
Innovent Releases Final Analysis Results of ORIENT-15: the Phase 3 Study of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma at the AACR Annual Meeting 2023 2023-04-17 08:33
1 72 73 74 75 76 375